Search research articles
Contact Us
Filters
Showing results (401-410 of 451) with videos related to
Page
of 46
Sort By:
Journal of Viral Hepatitis
|
January 19, 2024
Addition of PEG-interferon to long-term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg-negative chronic hepatitis B: Multicentre Randomized Trial (PAS Study)
Mina S Farag, Margo J H van Campenhout, M J Sonneveld, et al.
Nature Communications
|
January 31, 2019
Inactivating hepatitis C virus in donor lungs using light therapies during normothermic ex vivo lung perfusion
Marcos Galasso, Jordan J Feld, Yui Watanabe, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 17, 2025
Association of metabolic comorbidities with fibrosis severity and fibrosis regression in patients with chronic hepatitis B
Lisa M van Velsen, Lesley A Patmore, Jordan J Feld, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 2, 2023
Association Between the Presence of Metabolic Comorbidities and Liver-Related Events in Patients With Chronic Hepatitis B
Lesley A Patmore, Warshan K Katwaroe, Daniel van der Spek, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 16, 2023
Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs
Qinglu Cheng, Evan B Cunningham, Sophy Shih, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 14, 2019
Patterns of Drug and Alcohol Use and Injection Equipment Sharing Among People With Recent Injecting Drug Use or Receiving Opioid Agonist Treatment During and Following Hepatitis C Virus Treatment With Direct-acting Antiviral Therapies: An International Study
Andreea A Artenie, Evan B Cunningham, Gregory J Dore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 3, 2019
Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy
Evan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 14, 2020
Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject Drugs
Evan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
The Lancet. Gastroenterology & Hepatology
|
October 3, 2018
HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies
Marjolein van Tilborg, Saeed H Al Marzooqi, William W L Wong, et al.
Hepatology (Baltimore, Md.)
|
April 8, 2015
Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis
K Rajender Reddy, Marc Bourlière, Mark Sulkowski, et al.
Page
of 46
Search research articles
Search
Showing results (401-410 of 451) with videos related to
Sort By:
Page
of 46
Journal of Viral Hepatitis
|
January 19, 2024
Addition of PEG-interferon to long-term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg-negative chronic hepatitis B: Multicentre Randomized Trial (PAS Study)
Mina S Farag, Margo J H van Campenhout, M J Sonneveld, et al.
Nature Communications
|
January 31, 2019
Inactivating hepatitis C virus in donor lungs using light therapies during normothermic ex vivo lung perfusion
Marcos Galasso, Jordan J Feld, Yui Watanabe, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 17, 2025
Association of metabolic comorbidities with fibrosis severity and fibrosis regression in patients with chronic hepatitis B
Lisa M van Velsen, Lesley A Patmore, Jordan J Feld, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 2, 2023
Association Between the Presence of Metabolic Comorbidities and Liver-Related Events in Patients With Chronic Hepatitis B
Lesley A Patmore, Warshan K Katwaroe, Daniel van der Spek, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 16, 2023
Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs
Qinglu Cheng, Evan B Cunningham, Sophy Shih, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 14, 2019
Patterns of Drug and Alcohol Use and Injection Equipment Sharing Among People With Recent Injecting Drug Use or Receiving Opioid Agonist Treatment During and Following Hepatitis C Virus Treatment With Direct-acting Antiviral Therapies: An International Study
Andreea A Artenie, Evan B Cunningham, Gregory J Dore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 3, 2019
Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy
Evan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 14, 2020
Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject Drugs
Evan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
The Lancet. Gastroenterology & Hepatology
|
October 3, 2018
HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies
Marjolein van Tilborg, Saeed H Al Marzooqi, William W L Wong, et al.
Hepatology (Baltimore, Md.)
|
April 8, 2015
Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis
K Rajender Reddy, Marc Bourlière, Mark Sulkowski, et al.
Page
of 46